NSU Newsroom
SharkBytes
Horizons
This version of NSU News has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of NSU News, visit news.nova.edu.
This version of SharkBytes has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of SharkBytes, visit sharkbytes.nova.edu.
Institute for Neuro-Immune Medicine Offers Monthly Seminars, Feb. 5
NSU College of Medicine’s Institute for Neuro-Immune Medicine (INIM) invites everyone to the latest session of its monthly Research Seminar Series on Feb. 5. All seminars, held on the first Friday of the month, will be broadcast to regional campuses.
Join the INIM in the Chancellor’s Dining room in the Terry Building from 12:00-1:30 p.m. as Richard Jove, Ph.D., distinguished research professor and director, NSU Cell Therapy Institute presents, “Overview of the NSU Cell Therapy Institute.”
Richard Jove, Ph.D., in an accomplished cancer research scientist, professor who earned his doctoral degree at Columbia University in 1984 and trained as a postdoctoral fellow at the Rockefeller University in New York.
Jove began his independent research career in 1988 as assistant professor at the University of Michigan in Ann Arbor. In 1995, he was recruited to help establish the Moffitt NCI-designated Comprehensive Cancer Center in Tampa, where he was director of the Molecular Oncology Program and later associate director for basic science in the Moffitt Research Institute.
From 2005–2013, Jove was first chair of the Molecular Medicine Department and then director of the Beckman Research Institute as well as deputy director of the City of Hope NCI-designated Comprehensive Cancer Center in Los Angeles, California. Most recently, he served as the director of Vaccine & Gene Therapy Institute of Florida, before moving to NSU in 2015.
Jove has an extensive track record of major grant funding, patents issued and pending, and more 225 publications to date. The goal of the NSU Cell Therapy Institute is to develop new therapies that reverse diseases of aging—including cancer, heart disease and macular degeneration, as well as others. The primary therapeutic approaches include immunotherapy and regenerative medicine.